Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061596

President & CEO returned 18,069 shares (to the company)

  • President & CEO acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Grant or award : show line 1 in the form +55,000 207,504 D
2017-11-16 Returned to the company : show line 2 in the form −18,069 $44.23 $799,192 189,435 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-15 Grant or award : show line 3 in the form Stock Option +137,500 137,500 D
Loading xslF345X03/doc4.xml…